Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Praxis Precision Medicines, Inc. (PRAX) had Return on Tangible Equity of -15.78% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-69.30M |
|
-- |
|
-- |
|
$74.73M |
|
$-74.73M |
|
$5.43M |
|
$-69.30M |
|
$-69.30M |
|
$-69.30M |
|
$-69.30M |
|
$-69.30M |
|
$-69.30M |
|
$-74.73M |
|
$-75.91M |
|
21.06M |
|
21.06M |
|
$-3.29 |
|
$-3.29 |
|
| Balance Sheet Financials | |
$333.57M |
|
$0.25M |
|
$145.16M |
|
$478.74M |
|
$39.52M |
|
-- |
|
-- |
|
$39.52M |
|
$439.21M |
|
$439.21M |
|
$439.21M |
|
20.34M |
|
| Cash Flow Statement Financials | |
$-53.01M |
|
$-51.06M |
|
$54.27M |
|
$215.79M |
|
$165.98M |
|
$-49.80M |
|
$8.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-53.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.78% |
|
|
Return on Tangible Equity |
-15.78% |
-14.47% |
|
-15.78% |
|
$21.59 |
|
$-2.52 |
|
$-2.52 |
|